Skip to main content
. 2022 Jan 19;11(3):320. doi: 10.3390/cells11030320

Figure 2.

Figure 2

Tumor immune mechanism. T cells express PD-1 and CTLA-4 on their surface. Interaction with its ligands, PD-L1 and CD80/CD86, respectively, results in negative regulation of T cells. Therefore, anti-PD-1/PD-L1 and anti-CTLA-4 pathway antibodies would induce an upregulation of T cell activity.